Ding D Z, Shen T K, Cui Y Z
Research Section for Cardiovascular Diseases, Yanbian Medical College, Jilin.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 1995 Jun;15(6):325-7.
Forty-five patients with class IV cardiac function were divided into three groups: group I (digoxin group), group II (Red Ginseng group) and group III (Red Ginseng plus digoxin group). Each group consisted of 15 cases. After treatment, the improvement of the hemodynamical and biochemical indexes of group II and group III were greater than those of group I, and group III was the most significant amongst all. The results suggested that Red Ginseng and digoxin had synergism for treatment of congestive heart failure, and Red Ginseng was an effective and safe adjuvant without any side effects.
45例心功能IV级患者被分为三组：第一组（地高辛组）、第二组（红参组）和第三组（红参加地高辛组）。每组15例。治疗后，第二组和第三组的血流动力学和生化指标改善程度大于第一组，且第三组在所有组中最为显著。结果表明，红参与地高辛在治疗充血性心力衰竭方面具有协同作用，红参是一种有效且安全的辅助药物，无任何副作用。
